Ultimately, these findings may contribute to developing novel therapeutic strategies that could improve patient outcomes in HCC, emphasizing the importance of further investigations into the role of EZH2 in liver cancer biology. The gene discussed is EZH2; the disease is hepatocellular carcinoma.